Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced the launch of two new master mixes...
Environmental Impact Acquisition Corporation ("ENVI" or the "Company") announced that it had achieved a quorum for the special meeting of its shareholders to be...
Akeso, Inc. announces that the Ligufalimab (CD47 monoclonal antibody, research and development code: AK117, the novel immuno-oncology drug independently developed by the Company) and...
Recently, Nanjing Bioheng Biotech Co., Ltd. ( hereinafter referred to as Bioheng) announced that its anti-claudin 18.2 autologous CAR-T cell therapy product CTB001 received Orphan Drug Designation...
Regeneron Pharmaceuticals, Inc and Sanofi today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
